T
DGX icon

TOBAM’s Quest Diagnostics DGX Stock Holding History

TOBAM’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48
Closed -$7K – 327
2024
Q3 		$7K Sell
48
-243
-84% -$36.3K ﹤0.01% 319
2024
Q2 		$40K Sell
291
-465
-62% -$63.7K 0.01% 303
2024
Q1 		$101K Sell
756
-3,509
-82% -$455K 0.01% 293
2023
Q4 		$588K Sell
4,265
-5,004
-54% -$658K 0.05% 121
2023
Q3 		$1.13M Sell
9,269
-42,973
-82% -$5.73M 0.09% 88
2023
Q2 		$7.34M Sell
52,242
-108,829
-68% -$15M 0.55% 48
2023
Q1 		$22.8M Sell
161,071
-67,972
-30% -$9.72M 1.5% 28
2022
Q4 		$35.8M Sell
229,043
-30,800
-12% -$4.43M 2.37% 11
2022
Q3 		$31.9M Buy
259,843
+491
+0.2% +$64.7K 2.23% 11
2022
Q2 		$34.5M Buy
259,352
+179,847
+226% +$24.5M 2.16% 15
2022
Q1 		$10.9M Buy
79,505
+78,700
+9,776% +$11M 0.55% 58
2021
Q4 		$139K Buy
805
+348
+76% +$53K 0.01% 219
2021
Q3 		$66K Hold
457
– – ﹤0.01% 322
2021
Q2 		$60K Hold
457
– – ﹤0.01% 323
2021
Q1 		$59K Hold
457
– – ﹤0.01% 313
2020
Q4 		$54K Hold
457
– – ﹤0.01% 310
2020
Q3 		$52K Buy
+457
New +$54K ﹤0.01% 286
2020
Q2 		– Sell
-11,441
Closed -$919K – 152
2020
Q1 		$919K Buy
+11,441
New +$1.18M 0.07% 101
2015
Q1 		– Sell
-142,120
Closed -$9.53M – 146
2014
Q4 		$9.53M Sell
142,120
-1,722,732
-92% -$109M 0.32% 62
2014
Q3 		$113M Buy
1,864,852
+660,276
+55% +$40.7M 3.2% 5
2014
Q2 		$70.7M Buy
1,204,576
+510,949
+74% +$29.9M 3.13% 5
2014
Q1 		$40.2M Buy
693,627
+465,430
+204% +$24.9M 2% 18
2013
Q4 		$12.2M Buy
+228,197
New +$13.5M 0.63% 48

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TOBAM's DGX Position: Q4 2024 in Review

TOBAM sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 48 shares — an estimated $7K sold.

TOBAM first reported a position in DGX in Q4 2013 and held it in 23 quarters. The position peaked at $113M in Q3 2014. 897 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • TOBAM reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • TOBAM sold 48 Quest Diagnostics shares in Q4 2024, an estimated $7K.
  • TOBAM first reported a position in Quest Diagnostics in Q4 2013 and held it in 23 quarters.
  • TOBAM's Quest Diagnostics position peaked at $113M in Q3 2014.
  • 897 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on TOBAM's 13F filing for Q4 2024, filed 28 Jan 2025.